4.8 Article

The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase

期刊

SCIENCE
卷 336, 期 6083, 页码 918-922

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1215327

关键词

-

资金

  1. Wellcome Trust [080982]
  2. Medical Research Council
  3. AstraZeneca
  4. Boehringer-Ingelheim
  5. GlaxoSmithKline
  6. Merck Serono
  7. Pfizer
  8. Canadian Institutes of Health Research (CIHR)
  9. Canadian Diabetes Association
  10. National Health and Medical Research Council of Australia
  11. Australian Research Council
  12. Victorian Government
  13. Medical Research Council [MC_U127088492] Funding Source: researchfish
  14. MRC [MC_U127088492] Funding Source: UKRI

向作者/读者索取更多资源

Salicylate, a plant product, has been in medicinal use since ancient times. More recently, it has been replaced by synthetic derivatives such as aspirin and salsalate, both of which are rapidly broken down to salicylate in vivo. At concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cell growth and metabolism. Salicylate binds at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site, threonine-172. In AMPK knockout mice, effects of salicylate to increase fat utilization and to lower plasma fatty acids in vivo were lost. Our results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据